Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment.

作者信息

Mirošević Gorana, Nikolić Marko, Kruljac Ivan, Ljubičić Neven, Bekavac-Bešlin Miroslav, Milošević Milan, Nikolić Borka Pezo, Supanc Vladimir, Budimir Ivan, Vrkljan Milan

机构信息

Department of Endocrinology, Diabetology and Metabolic Diseases "Mladen Sekso", University Hospital Center "Sestre milosrdnice", University of Zagreb School of Medicine, Vinogradska cesta 29, Zagreb, Croatia.

出版信息

Endocrine. 2014 Mar;45(2):331-4. doi: 10.1007/s12020-013-0069-x. Epub 2013 Oct 17.

DOI:10.1007/s12020-013-0069-x

PMID:24132499

Abstract

摘要

相似文献

Decrease in insulin resistance has a key role in improvement of metabolic profile during intragastric balloon treatment.

Endocrine. 2014 Mar;45(2):331-4. doi: 10.1007/s12020-013-0069-x. Epub 2013 Oct 17.

Intragastric balloon treatment for obesity: results of a large single center prospective study.

Obes Surg. 2011 May;21(5):551-5. doi: 10.1007/s11695-010-0310-0.

Bariatric therapy with intragastric balloon improves liver dysfunction and insulin resistance in obese patients.

Obes Surg. 2008 Nov;18(11):1438-42. doi: 10.1007/s11695-008-9487-x. Epub 2008 Mar 28.

Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.

Obes Surg. 2011 Oct;21(10):1597-604. doi: 10.1007/s11695-011-0414-1.

Metabolic parameters after BioEnterics Intragastric Balloon placement in obese patients.

J Endocrinol Invest. 2009 Feb;32(2):165-8. doi: 10.1007/BF03345708.

Impact of Intragastric Balloon Treatment on Adipokines, Cytokines, and Metabolic Profile in Obese Individuals.

Obes Surg. 2019 Aug;29(8):2600-2608. doi: 10.1007/s11695-019-03891-8.

The REDUCE pivotal trial: a prospective, randomized controlled pivotal trial of a dual intragastric balloon for the treatment of obesity.

Surg Obes Relat Dis. 2015 Jul-Aug;11(4):874-81. doi: 10.1016/j.soard.2014.12.006. Epub 2014 Dec 16.

Endoscopic Balloon Therapy.

Surg Clin North Am. 2021 Apr;101(2):355-371. doi: 10.1016/j.suc.2020.12.009.

Gastric emptying of solids in morbid obesity.

Int J Obes Relat Metab Disord. 1996 Mar;20(3):200-5.

Obalon intragastric balloon in the treatment of paediatric obesity: a pilot study.

Pediatr Obes. 2015 Oct;10(5):e1-4. doi: 10.1111/ijpo.268. Epub 2014 Nov 14.

引用本文的文献

Intragastric Balloon Significantly Improves Metabolic Parameters at 6 Months: a Meta-Analysis.

Obes Surg. 2023 Mar;33(3):725-732. doi: 10.1007/s11695-022-06437-7. Epub 2023 Jan 12.

The Impact of Intragastric Balloons on Obesity-Related Co-Morbidities: A Systematic Review and Meta-Analysis.

Am J Gastroenterol. 2017 Mar;112(3):429-439. doi: 10.1038/ajg.2016.530. Epub 2017 Jan 24.

本文引用的文献

Insulin and norepinephrine regulate ghrelin secretion from a rat primary stomach cell culture.

Endocrinology. 2012 Aug;153(8):3646-56. doi: 10.1210/en.2012-1040. Epub 2012 Jun 12.

Long-term persistence of hormonal adaptations to weight loss.

N Engl J Med. 2011 Oct 27;365(17):1597-604. doi: 10.1056/NEJMoa1105816.

Morbidly obese are ghrelin and leptin hyporesponders with lesser intragastric balloon treatment efficiency : ghrelin and leptin changes in relation to obesity treatment.

Obes Surg. 2011 Oct;21(10):1597-604. doi: 10.1007/s11695-011-0414-1.

Obesity: Intragastric balloons--a bubble to combat the obesity bubble?

Nat Rev Gastroenterol Hepatol. 2010 Jan;7(1):7-8. doi: 10.1038/nrgastro.2009.214.

Impact of obesity on the growth hormone axis: evidence for a direct inhibitory effect of hyperinsulinemia on pituitary function.

Endocrinology. 2006 Jun;147(6):2754-63. doi: 10.1210/en.2005-1549. Epub 2006 Mar 2.

The human obesity gene map: the 2004 update.

Obes Res. 2005 Mar;13(3):381-490. doi: 10.1038/oby.2005.50.

Growth hormone treatment reduces abdominal visceral fat in postmenopausal women with abdominal obesity: a 12-month placebo-controlled trial.

J Clin Endocrinol Metab. 2005 Mar;90(3):1466-74. doi: 10.1210/jc.2004-1657. Epub 2004 Dec 14.

Resistin, adiponectin, ghrelin, leptin, and proinflammatory cytokines: relationships in obesity.

Obes Res. 2004 Jun;12(6):962-71. doi: 10.1038/oby.2004.118.

Growth hormone secretion and leptin in morbid obesity before and after biliopancreatic diversion: relationships with insulin and body composition.

J Clin Endocrinol Metab. 2004 Jan;89(1):174-80. doi: 10.1210/jc.2002-021308.

Adipose tissue as an endocrine and paracrine organ.

Int J Obes Relat Metab Disord. 1998 Dec;22(12):1145-58. doi: 10.1038/sj.ijo.0800770.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验